Cell type-specific enhancement of hepatitis C virus internal ribosome entry site-directed translation due to 5' nontranslated region substitutions selected during passage of virus in lymphoblastoid cells.
about
Antiviral activities of ISG20 in positive-strand RNA virus infectionsCompartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells.Mutation Master: profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions.Analysis of in vitro replicated human hepatitis C virus (HCV) for the determination of genotypes and quasispeciesEvolution of naturally occurring 5'non-coding region variants of Hepatitis C virus in human populations of the South American regionFrequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes.Novel nucleotide and amino acid covariation between the 5'UTR and the NS2/NS3 proteins of hepatitis C virus: bioinformatic and functional analyses.Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence.Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization.Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women.Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV.Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2.Correlation between translation efficiency and outcome of combination therapy in chronic hepatitis C genotype 3.Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants.Selection of different 5' untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infection.Hepatitis C infection of B lymphocytes: more tools to address pending questions.
P2860
Q24305035-AFFB49FC-2675-451C-834A-623BF8D71EBBQ27469508-C5D67B67-E856-4A83-9318-45D2DC86F3F7Q27472962-7D3A3C95-F420-4D09-9CC2-7CE6F494127FQ27477520-652D0ED8-30BC-4302-845B-5BB742EF53BFQ27481052-90CC8744-9617-4ED0-A6E9-73B5AA824382Q30758796-2AFE1782-F0B9-4A5B-9129-E27312881D03Q34043316-1CC298E0-1A93-4FAB-9A3E-28E33CFA8C53Q35124736-8654DA3A-7394-4870-A6CA-86FEF8264EF9Q35627530-908935D2-DD4C-4987-8D22-A8ABE10E794CQ35869344-955304AE-D582-43A5-B9FE-BF7F4DB23BE0Q36034450-D5D9433C-3243-4C3F-AE4E-140881C8F45DQ36244165-2740C8EB-8B54-47C2-A3B2-9846A71B2A42Q40325254-22D27D11-2BAA-49AC-A93C-381CBF59DEC1Q40815101-C5C945F8-1C74-46F5-A213-97A4D9276F3DQ43000786-2CD09595-FD7A-429D-B74F-F30AD60AEA48Q50558748-8300B6AB-C019-4821-AAD0-F3F817573819
P2860
Cell type-specific enhancement of hepatitis C virus internal ribosome entry site-directed translation due to 5' nontranslated region substitutions selected during passage of virus in lymphoblastoid cells.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cell type-specific enhancement ...... virus in lymphoblastoid cells
@nl
Cell type-specific enhancement ...... virus in lymphoblastoid cells.
@ast
Cell type-specific enhancement ...... virus in lymphoblastoid cells.
@en
type
label
Cell type-specific enhancement ...... virus in lymphoblastoid cells
@nl
Cell type-specific enhancement ...... virus in lymphoblastoid cells.
@ast
Cell type-specific enhancement ...... virus in lymphoblastoid cells.
@en
prefLabel
Cell type-specific enhancement ...... virus in lymphoblastoid cells
@nl
Cell type-specific enhancement ...... virus in lymphoblastoid cells.
@ast
Cell type-specific enhancement ...... virus in lymphoblastoid cells.
@en
P2093
P2860
P1433
P1476
Cell type-specific enhancement ...... virus in lymphoblastoid cells.
@en
P2093
P2860
P304
P356
10.1128/JVI.74.15.7024-7031.2000
P577
2000-08-01T00:00:00Z